nodes	percent_of_prediction	percent_of_DWPC	metapath
Chloropyramine—PTK2—exocrine gland—cervical cancer	0.102	0.195	CbGeAlD
Chloropyramine—PTK2—Irinotecan—Topotecan—cervical cancer	0.06	1	CbGdCrCtD
Chloropyramine—PTK2—Platelet Aggregation (Plug Formation)—GP5—cervical cancer	0.0465	0.112	CbGpPWpGaD
Chloropyramine—PTK2—epithelium—cervical cancer	0.0446	0.085	CbGeAlD
Chloropyramine—PTK2—uterine cervix—cervical cancer	0.0442	0.0843	CbGeAlD
Chloropyramine—PTK2—decidua—cervical cancer	0.0421	0.0803	CbGeAlD
Chloropyramine—PTK2—renal system—cervical cancer	0.0413	0.0788	CbGeAlD
Chloropyramine—PTK2—uterus—cervical cancer	0.0368	0.0702	CbGeAlD
Chloropyramine—PTK2—female reproductive system—cervical cancer	0.0331	0.0631	CbGeAlD
Chloropyramine—PTK2—female gonad—cervical cancer	0.0301	0.0574	CbGeAlD
Chloropyramine—PTK2—vagina—cervical cancer	0.0299	0.0571	CbGeAlD
Chloropyramine—PTK2—Androgen receptor signaling pathway—PIAS3—cervical cancer	0.0208	0.0501	CbGpPWpGaD
Chloropyramine—PTK2—lymph node—cervical cancer	0.0194	0.0369	CbGeAlD
Chloropyramine—HRH1—Amine ligand-binding receptors—TAAR6—cervical cancer	0.0162	0.0391	CbGpPWpGaD
Chloropyramine—HRH1—epithelium—cervical cancer	0.0139	0.0265	CbGeAlD
Chloropyramine—HRH1—uterine cervix—cervical cancer	0.0138	0.0263	CbGeAlD
Chloropyramine—PTK2—Androgen receptor signaling pathway—UBE3A—cervical cancer	0.0134	0.0323	CbGpPWpGaD
Chloropyramine—HRH1—decidua—cervical cancer	0.0131	0.025	CbGeAlD
Chloropyramine—PTK2—EGF/EGFR Signaling Pathway—PIAS3—cervical cancer	0.0129	0.031	CbGpPWpGaD
Chloropyramine—PTK2—Platelet activation, signaling and aggregation—GP6—cervical cancer	0.0127	0.0306	CbGpPWpGaD
Chloropyramine—HRH1—endometrium—cervical cancer	0.0125	0.0238	CbGeAlD
Chloropyramine—HRH1—mammalian vulva—cervical cancer	0.0121	0.023	CbGeAlD
Chloropyramine—PTK2—Platelet activation, signaling and aggregation—GP5—cervical cancer	0.0111	0.0268	CbGpPWpGaD
Chloropyramine—HRH1—female reproductive system—cervical cancer	0.0103	0.0197	CbGeAlD
Chloropyramine—HRH1—female gonad—cervical cancer	0.0094	0.0179	CbGeAlD
Chloropyramine—HRH1—vagina—cervical cancer	0.00934	0.0178	CbGeAlD
Chloropyramine—PTK2—Developmental Biology—INSM1—cervical cancer	0.0082	0.0197	CbGpPWpGaD
Chloropyramine—PTK2—Apoptotic cleavage of cellular proteins—CASP8—cervical cancer	0.00807	0.0194	CbGpPWpGaD
Chloropyramine—PTK2—Alpha 6 Beta 4 signaling pathway—MTOR—cervical cancer	0.00743	0.0179	CbGpPWpGaD
Chloropyramine—PTK2—Nectin adhesion pathway—CTNNB1—cervical cancer	0.00711	0.0171	CbGpPWpGaD
Chloropyramine—PTK2—Hemostasis—SERPIND1—cervical cancer	0.00656	0.0158	CbGpPWpGaD
Chloropyramine—PTK2—Hemostasis—GP6—cervical cancer	0.00656	0.0158	CbGpPWpGaD
Chloropyramine—PTK2—Apoptotic execution phase—CASP8—cervical cancer	0.00628	0.0151	CbGpPWpGaD
Chloropyramine—PTK2—Apoptotic cleavage of cellular proteins—CASP3—cervical cancer	0.00611	0.0147	CbGpPWpGaD
Chloropyramine—HRH1—lymph node—cervical cancer	0.00604	0.0115	CbGeAlD
Chloropyramine—PTK2—Nanoparticle-mediated activation of receptor signaling—EGFR—cervical cancer	0.00596	0.0143	CbGpPWpGaD
Chloropyramine—PTK2—Apoptotic cleavage of cellular proteins—CTNNB1—cervical cancer	0.00589	0.0142	CbGpPWpGaD
Chloropyramine—PTK2—Caspase Cascade in Apoptosis—CASP8—cervical cancer	0.00584	0.014	CbGpPWpGaD
Chloropyramine—PTK2—Hemostasis—GP5—cervical cancer	0.00573	0.0138	CbGpPWpGaD
Chloropyramine—PTK2—Signaling of Hepatocyte Growth Factor Receptor—STAT3—cervical cancer	0.00561	0.0135	CbGpPWpGaD
Chloropyramine—PTK2—Integrins in angiogenesis—CASP8—cervical cancer	0.00539	0.013	CbGpPWpGaD
Chloropyramine—PTK2—Primary Focal Segmental Glomerulosclerosis FSGS—NOTCH1—cervical cancer	0.00532	0.0128	CbGpPWpGaD
Chloropyramine—PTK2—ErbB Signaling Pathway—MTOR—cervical cancer	0.00501	0.0121	CbGpPWpGaD
Chloropyramine—PTK2—RANKL/RANK Signaling Pathway—MTOR—cervical cancer	0.00494	0.0119	CbGpPWpGaD
Chloropyramine—PTK2—Apoptotic execution phase—CASP3—cervical cancer	0.00475	0.0114	CbGpPWpGaD
Chloropyramine—PTK2—Internalization of ErbB1—EGFR—cervical cancer	0.00466	0.0112	CbGpPWpGaD
Chloropyramine—PTK2—Apoptotic execution phase—CTNNB1—cervical cancer	0.00458	0.011	CbGpPWpGaD
Chloropyramine—PTK2—Caspase Cascade in Apoptosis—CASP3—cervical cancer	0.00442	0.0106	CbGpPWpGaD
Chloropyramine—PTK2—LPA receptor mediated events—CASP3—cervical cancer	0.00403	0.00968	CbGpPWpGaD
Chloropyramine—PTK2—Leptin signaling pathway—MTOR—cervical cancer	0.00385	0.00927	CbGpPWpGaD
Chloropyramine—PTK2—TGF-beta Signaling Pathway—TERT—cervical cancer	0.0038	0.00914	CbGpPWpGaD
Chloropyramine—PTK2—Rac1/Pak1/p38/MMP-2 pathway—CTNNB1—cervical cancer	0.00374	0.009	CbGpPWpGaD
Chloropyramine—PTK2—Signaling events mediated by VEGFR1 and VEGFR2—CTNNB1—cervical cancer	0.0037	0.00889	CbGpPWpGaD
Chloropyramine—PTK2—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—MTOR—cervical cancer	0.00366	0.00881	CbGpPWpGaD
Chloropyramine—PTK2—Primary Focal Segmental Glomerulosclerosis FSGS—CTNNB1—cervical cancer	0.00353	0.00849	CbGpPWpGaD
Chloropyramine—PTK2—ErbB Signaling Pathway—EGFR—cervical cancer	0.00352	0.00847	CbGpPWpGaD
Chloropyramine—PTK2—CXCR4-mediated signaling events—MTOR—cervical cancer	0.00352	0.00847	CbGpPWpGaD
Chloropyramine—PTK2—CXCR4-mediated signaling events—CD4—cervical cancer	0.00351	0.00845	CbGpPWpGaD
Chloropyramine—PTK2—Rac1/Pak1/p38/MMP-2 pathway—STAT3—cervical cancer	0.00326	0.00784	CbGpPWpGaD
Chloropyramine—PTK2—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—CTNNB1—cervical cancer	0.00325	0.00781	CbGpPWpGaD
Chloropyramine—HRH1—Class A/1 (Rhodopsin-like receptors)—TAAR6—cervical cancer	0.0032	0.00769	CbGpPWpGaD
Chloropyramine—PTK2—Regulation of Actin Cytoskeleton—FGFR3—cervical cancer	0.00316	0.00761	CbGpPWpGaD
Chloropyramine—PTK2—LPA receptor mediated events—EGFR—cervical cancer	0.00307	0.00739	CbGpPWpGaD
Chloropyramine—PTK2—Corticotropin-releasing hormone—CASP3—cervical cancer	0.00301	0.00724	CbGpPWpGaD
Chloropyramine—PTK2—Androgen receptor signaling pathway—CTNNB1—cervical cancer	0.00298	0.00717	CbGpPWpGaD
Chloropyramine—PTK2—Leptin signaling pathway—STAT3—cervical cancer	0.00298	0.00717	CbGpPWpGaD
Chloropyramine—PTK2—Rac1/Pak1/p38/MMP-2 pathway—EGFR—cervical cancer	0.00296	0.00713	CbGpPWpGaD
Chloropyramine—PTK2—ErbB Signaling Pathway—TP53—cervical cancer	0.00296	0.00711	CbGpPWpGaD
Chloropyramine—PTK2—Corticotropin-releasing hormone—CTNNB1—cervical cancer	0.0029	0.00698	CbGpPWpGaD
Chloropyramine—PTK2—VEGFA-VEGFR2 Pathway—MTOR—cervical cancer	0.0029	0.00698	CbGpPWpGaD
Chloropyramine—PTK2—Signaling by VEGF—MTOR—cervical cancer	0.00274	0.00659	CbGpPWpGaD
Chloropyramine—PTK2—CXCR4-mediated signaling events—STAT3—cervical cancer	0.00272	0.00655	CbGpPWpGaD
Chloropyramine—PTK2—Apoptosis—CASP8—cervical cancer	0.00262	0.00631	CbGpPWpGaD
Chloropyramine—PTK2—Androgen receptor signaling pathway—STAT3—cervical cancer	0.0026	0.00625	CbGpPWpGaD
Chloropyramine—PTK2—VEGFA-VEGFR2 Pathway—CTNNB1—cervical cancer	0.00257	0.00619	CbGpPWpGaD
Chloropyramine—PTK2—Rac1/Pak1/p38/MMP-2 pathway—TP53—cervical cancer	0.00249	0.00599	CbGpPWpGaD
Chloropyramine—HRH1—GPCR ligand binding—TAAR6—cervical cancer	0.00243	0.00585	CbGpPWpGaD
Chloropyramine—PTK2—Signaling by VEGF—CTNNB1—cervical cancer	0.00243	0.00584	CbGpPWpGaD
Chloropyramine—PTK2—Androgen receptor signaling pathway—EGFR—cervical cancer	0.00236	0.00568	CbGpPWpGaD
Chloropyramine—PTK2—Cell-Cell communication—CTNNB1—cervical cancer	0.0022	0.00529	CbGpPWpGaD
Chloropyramine—PTK2—EGF/EGFR Signaling Pathway—MTOR—cervical cancer	0.00208	0.00501	CbGpPWpGaD
Chloropyramine—PTK2—Apoptosis—CASP3—cervical cancer	0.00198	0.00477	CbGpPWpGaD
Chloropyramine—HRH1—IL-4 Signaling Pathway—STAT3—cervical cancer	0.00194	0.00467	CbGpPWpGaD
Chloropyramine—PTK2—Apoptosis—CTNNB1—cervical cancer	0.00191	0.0046	CbGpPWpGaD
Chloropyramine—HRH1—GPCR ligand binding—WNT2—cervical cancer	0.0019	0.00457	CbGpPWpGaD
Chloropyramine—PTK2—Immune System—UBE3A—cervical cancer	0.00175	0.00422	CbGpPWpGaD
Chloropyramine—PTK2—Focal Adhesion—CTNNB1—cervical cancer	0.00162	0.00391	CbGpPWpGaD
Chloropyramine—PTK2—EGF/EGFR Signaling Pathway—STAT3—cervical cancer	0.00161	0.00387	CbGpPWpGaD
Chloropyramine—PTK2—Regulation of Actin Cytoskeleton—EGFR—cervical cancer	0.00156	0.00376	CbGpPWpGaD
Chloropyramine—PTK2—Developmental Biology—HES1—cervical cancer	0.00151	0.00363	CbGpPWpGaD
Chloropyramine—PTK2—Signaling Pathways—TAAR6—cervical cancer	0.00147	0.00354	CbGpPWpGaD
Chloropyramine—PTK2—EGF/EGFR Signaling Pathway—EGFR—cervical cancer	0.00146	0.00352	CbGpPWpGaD
Chloropyramine—PTK2—TGF-beta Signaling Pathway—TP53—cervical cancer	0.00145	0.00348	CbGpPWpGaD
Chloropyramine—HRH1—GPCR ligand binding—WNT5A—cervical cancer	0.00144	0.00346	CbGpPWpGaD
Chloropyramine—HRH1—GPCR downstream signaling—TAAR6—cervical cancer	0.00138	0.00331	CbGpPWpGaD
Chloropyramine—PTK2—Focal Adhesion—EGFR—cervical cancer	0.00129	0.0031	CbGpPWpGaD
Chloropyramine—PTK2—Apoptosis—TP53—cervical cancer	0.00127	0.00306	CbGpPWpGaD
Chloropyramine—HRH1—Signaling by GPCR—TAAR6—cervical cancer	0.00125	0.003	CbGpPWpGaD
Chloropyramine—PTK2—Signaling Pathways—WNT2—cervical cancer	0.00115	0.00277	CbGpPWpGaD
Chloropyramine—PTK2—Developmental Biology—NOTCH1—cervical cancer	0.00114	0.00274	CbGpPWpGaD
Chloropyramine—PTK2—Innate Immune System—FGFR3—cervical cancer	0.00107	0.00258	CbGpPWpGaD
Chloropyramine—PTK2—Immune System—HLA-DPB1—cervical cancer	0.00105	0.00252	CbGpPWpGaD
Chloropyramine—PTK2—Signaling Pathways—AKAP13—cervical cancer	0.00101	0.00243	CbGpPWpGaD
Chloropyramine—HRH1—Signaling by GPCR—WNT2—cervical cancer	0.000975	0.00235	CbGpPWpGaD
Chloropyramine—HRH1—GPCR downstream signaling—AKAP13—cervical cancer	0.000943	0.00227	CbGpPWpGaD
Chloropyramine—PTK2—Innate Immune System—CASP8—cervical cancer	0.000916	0.0022	CbGpPWpGaD
Chloropyramine—PTK2—Signaling Pathways—WNT5A—cervical cancer	0.000872	0.0021	CbGpPWpGaD
Chloropyramine—HRH1—Signaling by GPCR—AKAP13—cervical cancer	0.000856	0.00206	CbGpPWpGaD
Chloropyramine—PTK2—Axon guidance—EGFR—cervical cancer	0.00084	0.00202	CbGpPWpGaD
Chloropyramine—PTK2—Immune System—HLA-DQB1—cervical cancer	0.000817	0.00197	CbGpPWpGaD
Chloropyramine—PTK2—Immune System—CD8A—cervical cancer	0.000763	0.00183	CbGpPWpGaD
Chloropyramine—PTK2—Developmental Biology—CTNNB1—cervical cancer	0.000756	0.00182	CbGpPWpGaD
Chloropyramine—PTK2—Innate Immune System—MTOR—cervical cancer	0.000754	0.00181	CbGpPWpGaD
Chloropyramine—PTK2—Innate Immune System—CD4—cervical cancer	0.000752	0.00181	CbGpPWpGaD
Chloropyramine—HRH1—Signaling by GPCR—WNT5A—cervical cancer	0.000739	0.00178	CbGpPWpGaD
Chloropyramine—HRH1—Signaling Pathways—TAAR6—cervical cancer	0.000738	0.00177	CbGpPWpGaD
Chloropyramine—PTK2—Innate Immune System—CTNNB1—cervical cancer	0.000668	0.00161	CbGpPWpGaD
Chloropyramine—PTK2—Developmental Biology—STAT3—cervical cancer	0.000659	0.00159	CbGpPWpGaD
Chloropyramine—PTK2—Immune System—FGFR3—cervical cancer	0.000624	0.0015	CbGpPWpGaD
Chloropyramine—PTK2—Signaling Pathways—NOTCH2—cervical cancer	0.000612	0.00147	CbGpPWpGaD
Chloropyramine—PTK2—Developmental Biology—EGFR—cervical cancer	0.000599	0.00144	CbGpPWpGaD
Chloropyramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—cervical cancer	0.000584	0.0014	CbGpPWpGaD
Chloropyramine—HRH1—Signaling Pathways—WNT2—cervical cancer	0.000576	0.00139	CbGpPWpGaD
Chloropyramine—PTK2—Immune System—CASP8—cervical cancer	0.000533	0.00128	CbGpPWpGaD
Chloropyramine—PTK2—Innate Immune System—EGFR—cervical cancer	0.000529	0.00127	CbGpPWpGaD
Chloropyramine—HRH1—Signaling Pathways—AKAP13—cervical cancer	0.000506	0.00122	CbGpPWpGaD
Chloropyramine—PTK2—Signaling Pathways—HES1—cervical cancer	0.000502	0.00121	CbGpPWpGaD
Chloropyramine—PTK2—Hemostasis—TP53—cervical cancer	0.000494	0.00119	CbGpPWpGaD
Chloropyramine—PTK2—Signaling Pathways—TERT—cervical cancer	0.00044	0.00106	CbGpPWpGaD
Chloropyramine—PTK2—Immune System—MTOR—cervical cancer	0.000439	0.00106	CbGpPWpGaD
Chloropyramine—PTK2—Immune System—CD4—cervical cancer	0.000438	0.00105	CbGpPWpGaD
Chloropyramine—HRH1—Signaling Pathways—WNT5A—cervical cancer	0.000436	0.00105	CbGpPWpGaD
Chloropyramine—PTK2—Signaling Pathways—FGFR3—cervical cancer	0.000403	0.00097	CbGpPWpGaD
Chloropyramine—PTK2—Immune System—CTNNB1—cervical cancer	0.000389	0.000936	CbGpPWpGaD
Chloropyramine—PTK2—Signaling Pathways—NOTCH1—cervical cancer	0.000379	0.000911	CbGpPWpGaD
Chloropyramine—PTK2—Immune System—STAT3—cervical cancer	0.000339	0.000816	CbGpPWpGaD
Chloropyramine—PTK2—Immune System—EGFR—cervical cancer	0.000308	0.000742	CbGpPWpGaD
Chloropyramine—HRH1—Signaling Pathways—NOTCH2—cervical cancer	0.000306	0.000737	CbGpPWpGaD
Chloropyramine—PTK2—Signaling Pathways—MTOR—cervical cancer	0.000284	0.000683	CbGpPWpGaD
Chloropyramine—PTK2—Signaling Pathways—CASP3—cervical cancer	0.000261	0.000628	CbGpPWpGaD
Chloropyramine—PTK2—Signaling Pathways—CTNNB1—cervical cancer	0.000252	0.000605	CbGpPWpGaD
Chloropyramine—HRH1—Signaling Pathways—HES1—cervical cancer	0.000251	0.000604	CbGpPWpGaD
Chloropyramine—HRH1—Signaling Pathways—TERT—cervical cancer	0.00022	0.000529	CbGpPWpGaD
Chloropyramine—PTK2—Signaling Pathways—STAT3—cervical cancer	0.000219	0.000528	CbGpPWpGaD
Chloropyramine—HRH1—Signaling Pathways—FGFR3—cervical cancer	0.000202	0.000486	CbGpPWpGaD
Chloropyramine—PTK2—Signaling Pathways—EGFR—cervical cancer	0.000199	0.000479	CbGpPWpGaD
Chloropyramine—HRH1—Signaling Pathways—NOTCH1—cervical cancer	0.00019	0.000456	CbGpPWpGaD
Chloropyramine—HRH1—Signaling by GPCR—EGFR—cervical cancer	0.000169	0.000406	CbGpPWpGaD
Chloropyramine—PTK2—Signaling Pathways—TP53—cervical cancer	0.000167	0.000403	CbGpPWpGaD
Chloropyramine—HRH1—Signaling Pathways—MTOR—cervical cancer	0.000142	0.000342	CbGpPWpGaD
Chloropyramine—HRH1—Signaling Pathways—CASP3—cervical cancer	0.000131	0.000314	CbGpPWpGaD
Chloropyramine—HRH1—Signaling Pathways—CTNNB1—cervical cancer	0.000126	0.000303	CbGpPWpGaD
Chloropyramine—HRH1—Signaling Pathways—STAT3—cervical cancer	0.00011	0.000264	CbGpPWpGaD
Chloropyramine—HRH1—Signaling Pathways—EGFR—cervical cancer	9.98e-05	0.00024	CbGpPWpGaD
Chloropyramine—HRH1—Signaling Pathways—TP53—cervical cancer	8.38e-05	0.000202	CbGpPWpGaD
